An anti-tumor role for cGMP-dependent protein kinase

Cancer Lett. 2006 Aug 18;240(1):60-8. doi: 10.1016/j.canlet.2005.08.035. Epub 2005 Oct 25.

Abstract

This study compared Type-1 cGMP-dependent protein kinase (PKG) expression in normal and tumor tissues and examined PKG function in tumor growth. Studies with a cDNA array revealed that PKG expression was reduced in many tumors compared to respective normal tissue. This decrease in PKG expression was confirmed using quantitative RT-PCR and western blotting of matched colon specimens from normal epithelium and tumor tissue, and also in colon derived cell lines where luciferase reporter analysis revealed that the decreased expression occurred at the transcriptional level. Using SW620 colon carcinoma cells engineered for inducible expression of PKG1beta, it was found that exogenous PKG1beta lead to decreased tumor growth and invasiveness in nude mouse xenografts.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma / enzymology*
  • Adenocarcinoma / genetics
  • Animals
  • Cell Line, Tumor
  • Colorectal Neoplasms / enzymology*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Cyclic GMP-Dependent Protein Kinases / biosynthesis
  • Cyclic GMP-Dependent Protein Kinases / genetics
  • Cyclic GMP-Dependent Protein Kinases / metabolism*
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic*
  • Genes, Reporter
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Promoter Regions, Genetic
  • RNA, Messenger / metabolism
  • Tissue Array Analysis
  • Transcription, Genetic
  • Transfection

Substances

  • RNA, Messenger
  • Cyclic GMP-Dependent Protein Kinases